Former U.S. patent head on why federal march-in rights for drugs would be a ‘devastating’ mistake

A Biden administration proposal to seize patents for drugs deemed too pricey would have a ripple effect that cuts into the heart of innovation, says former U.S. PTO head Andrei Iancu.